nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—CYP1A1—head and neck cancer	0.557	1	CbGaD
Propranolol—SLC22A2—Vinblastine—head and neck cancer	0.0865	0.233	CbGbCtD
Propranolol—CYP2D6—Hydroxyurea—head and neck cancer	0.0613	0.165	CbGbCtD
Propranolol—CYP3A7—Docetaxel—head and neck cancer	0.0389	0.104	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0389	0.104	CbGbCtD
Propranolol—CYP3A5—Docetaxel—head and neck cancer	0.0292	0.0784	CbGbCtD
Propranolol—CYP1A2—Fluorouracil—head and neck cancer	0.0284	0.0764	CbGbCtD
Propranolol—ABCB1—Vinblastine—head and neck cancer	0.023	0.0619	CbGbCtD
Propranolol—CYP2D6—Vinblastine—head and neck cancer	0.0217	0.0583	CbGbCtD
Propranolol—ABCB1—Docetaxel—head and neck cancer	0.019	0.051	CbGbCtD
Propranolol—CYP3A4—Vinblastine—head and neck cancer	0.0138	0.0371	CbGbCtD
Propranolol—CYP3A4—Docetaxel—head and neck cancer	0.0114	0.0306	CbGbCtD
Propranolol—Systemic lupus erythematosus—Hydroxyurea—head and neck cancer	0.00225	0.0392	CcSEcCtD
Propranolol—Colitis ischaemic—Docetaxel—head and neck cancer	0.0022	0.0384	CcSEcCtD
Propranolol—Lower respiratory tract infection—Docetaxel—head and neck cancer	0.0019	0.033	CcSEcCtD
Propranolol—Skin ulcer—Hydroxyurea—head and neck cancer	0.0016	0.0279	CcSEcCtD
Propranolol—Systemic lupus erythematosus—Docetaxel—head and neck cancer	0.00117	0.0204	CcSEcCtD
Propranolol—Disorientation—Hydroxyurea—head and neck cancer	0.00101	0.0176	CcSEcCtD
Propranolol—Throat sore—Docetaxel—head and neck cancer	0.000898	0.0156	CcSEcCtD
Propranolol—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.00089	0.0155	CcSEcCtD
Propranolol—Rash erythematous—Docetaxel—head and neck cancer	0.000845	0.0147	CcSEcCtD
Propranolol—Depression—Vinblastine—head and neck cancer	0.000762	0.0133	CcSEcCtD
Propranolol—Neutropenia—Hydroxyurea—head and neck cancer	0.000731	0.0127	CcSEcCtD
Propranolol—Disorientation—Fluorouracil—head and neck cancer	0.000728	0.0127	CcSEcCtD
Propranolol—Agranulocytosis—Vinblastine—head and neck cancer	0.000713	0.0124	CcSEcCtD
Propranolol—Oropharyngeal pain—Docetaxel—head and neck cancer	0.000712	0.0124	CcSEcCtD
Propranolol—Infestation—Hydroxyurea—head and neck cancer	0.000697	0.0121	CcSEcCtD
Propranolol—Infestation NOS—Hydroxyurea—head and neck cancer	0.000697	0.0121	CcSEcCtD
Propranolol—Amnesia—Fluorouracil—head and neck cancer	0.000693	0.0121	CcSEcCtD
Propranolol—Pharyngitis—Vinblastine—head and neck cancer	0.000681	0.0119	CcSEcCtD
Propranolol—Lethargy—Fluorouracil—head and neck cancer	0.000664	0.0116	CcSEcCtD
Propranolol—Hallucination—Hydroxyurea—head and neck cancer	0.000623	0.0108	CcSEcCtD
Propranolol—Irritability—Fluorouracil—head and neck cancer	0.000621	0.0108	CcSEcCtD
Propranolol—Cardiac arrest—Fluorouracil—head and neck cancer	0.000619	0.0108	CcSEcCtD
Propranolol—Alopecia—Vinblastine—head and neck cancer	0.000606	0.0106	CcSEcCtD
Propranolol—Lightheadedness—Docetaxel—head and neck cancer	0.000579	0.0101	CcSEcCtD
Propranolol—Carvedilol—VEGFA—head and neck cancer	0.000553	0.674	CrCbGaD
Propranolol—Alopecia—Hydroxyurea—head and neck cancer	0.000553	0.00963	CcSEcCtD
Propranolol—Erythema—Hydroxyurea—head and neck cancer	0.000545	0.00949	CcSEcCtD
Propranolol—Vertigo—Vinblastine—head and neck cancer	0.000537	0.00935	CcSEcCtD
Propranolol—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000518	0.00903	CcSEcCtD
Propranolol—Convulsion—Vinblastine—head and neck cancer	0.000518	0.00901	CcSEcCtD
Propranolol—Infestation NOS—Fluorouracil—head and neck cancer	0.000502	0.00874	CcSEcCtD
Propranolol—Infestation—Fluorouracil—head and neck cancer	0.000502	0.00874	CcSEcCtD
Propranolol—Visual disturbance—Docetaxel—head and neck cancer	0.000496	0.00864	CcSEcCtD
Propranolol—Lethargy—Docetaxel—head and neck cancer	0.00048	0.00835	CcSEcCtD
Propranolol—Convulsion—Hydroxyurea—head and neck cancer	0.000472	0.00822	CcSEcCtD
Propranolol—Agranulocytosis—Fluorouracil—head and neck cancer	0.000468	0.00816	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000461	0.00802	CcSEcCtD
Propranolol—Pharyngitis—Fluorouracil—head and neck cancer	0.000447	0.00779	CcSEcCtD
Propranolol—Infection—Hydroxyurea—head and neck cancer	0.000442	0.00769	CcSEcCtD
Propranolol—Paraesthesia—Vinblastine—head and neck cancer	0.000438	0.00762	CcSEcCtD
Propranolol—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000436	0.00759	CcSEcCtD
Propranolol—Skin disorder—Hydroxyurea—head and neck cancer	0.000432	0.00752	CcSEcCtD
Propranolol—Decreased appetite—Vinblastine—head and neck cancer	0.000424	0.00738	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000423	0.00737	CcSEcCtD
Propranolol—Pain—Vinblastine—head and neck cancer	0.000417	0.00726	CcSEcCtD
Propranolol—Constipation—Vinblastine—head and neck cancer	0.000417	0.00726	CcSEcCtD
Propranolol—Bronchospasm—Docetaxel—head and neck cancer	0.0004	0.00696	CcSEcCtD
Propranolol—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000399	0.00694	CcSEcCtD
Propranolol—Alopecia—Fluorouracil—head and neck cancer	0.000398	0.00693	CcSEcCtD
Propranolol—Dyspnoea—Hydroxyurea—head and neck cancer	0.000396	0.0069	CcSEcCtD
Propranolol—Somnolence—Hydroxyurea—head and neck cancer	0.000395	0.00688	CcSEcCtD
Propranolol—Erythema—Fluorouracil—head and neck cancer	0.000392	0.00683	CcSEcCtD
Propranolol—Dyspepsia—Hydroxyurea—head and neck cancer	0.000391	0.00682	CcSEcCtD
Propranolol—Decreased appetite—Hydroxyurea—head and neck cancer	0.000386	0.00673	CcSEcCtD
Propranolol—Abdominal pain—Vinblastine—head and neck cancer	0.000385	0.00671	CcSEcCtD
Propranolol—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000384	0.00669	CcSEcCtD
Propranolol—Fatigue—Hydroxyurea—head and neck cancer	0.000383	0.00668	CcSEcCtD
Propranolol—Pain—Hydroxyurea—head and neck cancer	0.00038	0.00662	CcSEcCtD
Propranolol—Constipation—Hydroxyurea—head and neck cancer	0.00038	0.00662	CcSEcCtD
Propranolol—Neutropenia—Docetaxel—head and neck cancer	0.00038	0.00662	CcSEcCtD
Propranolol—Infestation NOS—Docetaxel—head and neck cancer	0.000362	0.00631	CcSEcCtD
Propranolol—Infestation—Docetaxel—head and neck cancer	0.000362	0.00631	CcSEcCtD
Propranolol—Hypersensitivity—Vinblastine—head and neck cancer	0.000359	0.00626	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000359	0.00625	CcSEcCtD
Propranolol—Body temperature increased—Hydroxyurea—head and neck cancer	0.000351	0.00612	CcSEcCtD
Propranolol—Asthenia—Vinblastine—head and neck cancer	0.00035	0.00609	CcSEcCtD
Propranolol—Convulsion—Fluorouracil—head and neck cancer	0.00034	0.00592	CcSEcCtD
Propranolol—Agranulocytosis—Docetaxel—head and neck cancer	0.000338	0.00589	CcSEcCtD
Propranolol—Diarrhoea—Vinblastine—head and neck cancer	0.000334	0.00581	CcSEcCtD
Propranolol—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000328	0.00571	CcSEcCtD
Propranolol—Pharyngitis—Docetaxel—head and neck cancer	0.000323	0.00562	CcSEcCtD
Propranolol—Dizziness—Vinblastine—head and neck cancer	0.000322	0.00561	CcSEcCtD
Propranolol—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00032	0.00557	CcSEcCtD
Propranolol—Asthenia—Hydroxyurea—head and neck cancer	0.000319	0.00556	CcSEcCtD
Propranolol—Infection—Fluorouracil—head and neck cancer	0.000318	0.00554	CcSEcCtD
Propranolol—Nervous system disorder—Fluorouracil—head and neck cancer	0.000314	0.00547	CcSEcCtD
Propranolol—Visual impairment—Docetaxel—head and neck cancer	0.000313	0.00546	CcSEcCtD
Propranolol—Vomiting—Vinblastine—head and neck cancer	0.00031	0.0054	CcSEcCtD
Propranolol—Erythema multiforme—Docetaxel—head and neck cancer	0.000307	0.00535	CcSEcCtD
Propranolol—Diarrhoea—Hydroxyurea—head and neck cancer	0.000304	0.0053	CcSEcCtD
Propranolol—Cardiac disorder—Docetaxel—head and neck cancer	0.000302	0.00526	CcSEcCtD
Propranolol—Dizziness—Hydroxyurea—head and neck cancer	0.000294	0.00512	CcSEcCtD
Propranolol—Nausea—Vinblastine—head and neck cancer	0.00029	0.00504	CcSEcCtD
Propranolol—Insomnia—Fluorouracil—head and neck cancer	0.000289	0.00504	CcSEcCtD
Propranolol—Paraesthesia—Fluorouracil—head and neck cancer	0.000287	0.005	CcSEcCtD
Propranolol—Alopecia—Docetaxel—head and neck cancer	0.000287	0.005	CcSEcCtD
Propranolol—Dyspnoea—Fluorouracil—head and neck cancer	0.000285	0.00497	CcSEcCtD
Propranolol—Mental disorder—Docetaxel—head and neck cancer	0.000285	0.00496	CcSEcCtD
Propranolol—Somnolence—Fluorouracil—head and neck cancer	0.000284	0.00495	CcSEcCtD
Propranolol—Erythema—Docetaxel—head and neck cancer	0.000283	0.00493	CcSEcCtD
Propranolol—Vomiting—Hydroxyurea—head and neck cancer	0.000283	0.00492	CcSEcCtD
Propranolol—Dyspepsia—Fluorouracil—head and neck cancer	0.000282	0.00491	CcSEcCtD
Propranolol—Rash—Hydroxyurea—head and neck cancer	0.00028	0.00488	CcSEcCtD
Propranolol—Dermatitis—Hydroxyurea—head and neck cancer	0.00028	0.00488	CcSEcCtD
Propranolol—Decreased appetite—Fluorouracil—head and neck cancer	0.000278	0.00485	CcSEcCtD
Propranolol—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000276	0.00481	CcSEcCtD
Propranolol—Pain—Fluorouracil—head and neck cancer	0.000274	0.00477	CcSEcCtD
Propranolol—Carvedilol—CYP1A1—head and neck cancer	0.000267	0.326	CrCbGaD
Propranolol—Nausea—Hydroxyurea—head and neck cancer	0.000264	0.0046	CcSEcCtD
Propranolol—Urticaria—Fluorouracil—head and neck cancer	0.000254	0.00443	CcSEcCtD
Propranolol—Body temperature increased—Fluorouracil—head and neck cancer	0.000253	0.00441	CcSEcCtD
Propranolol—Cough—Docetaxel—head and neck cancer	0.000247	0.0043	CcSEcCtD
Propranolol—Convulsion—Docetaxel—head and neck cancer	0.000245	0.00427	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000239	0.00417	CcSEcCtD
Propranolol—Hypersensitivity—Fluorouracil—head and neck cancer	0.000236	0.00411	CcSEcCtD
Propranolol—Anaphylactic shock—Docetaxel—head and neck cancer	0.000231	0.00402	CcSEcCtD
Propranolol—Infection—Docetaxel—head and neck cancer	0.000229	0.004	CcSEcCtD
Propranolol—Nervous system disorder—Docetaxel—head and neck cancer	0.000227	0.00395	CcSEcCtD
Propranolol—Skin disorder—Docetaxel—head and neck cancer	0.000224	0.00391	CcSEcCtD
Propranolol—Diarrhoea—Fluorouracil—head and neck cancer	0.000219	0.00381	CcSEcCtD
Propranolol—Dizziness—Fluorouracil—head and neck cancer	0.000212	0.00369	CcSEcCtD
Propranolol—Insomnia—Docetaxel—head and neck cancer	0.000209	0.00364	CcSEcCtD
Propranolol—Paraesthesia—Docetaxel—head and neck cancer	0.000207	0.00361	CcSEcCtD
Propranolol—Dyspnoea—Docetaxel—head and neck cancer	0.000206	0.00359	CcSEcCtD
Propranolol—Somnolence—Docetaxel—head and neck cancer	0.000205	0.00358	CcSEcCtD
Propranolol—Vomiting—Fluorouracil—head and neck cancer	0.000203	0.00354	CcSEcCtD
Propranolol—Dyspepsia—Docetaxel—head and neck cancer	0.000203	0.00354	CcSEcCtD
Propranolol—Rash—Fluorouracil—head and neck cancer	0.000202	0.00351	CcSEcCtD
Propranolol—Dermatitis—Fluorouracil—head and neck cancer	0.000202	0.00351	CcSEcCtD
Propranolol—Decreased appetite—Docetaxel—head and neck cancer	0.000201	0.0035	CcSEcCtD
Propranolol—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000199	0.00347	CcSEcCtD
Propranolol—Fatigue—Docetaxel—head and neck cancer	0.000199	0.00347	CcSEcCtD
Propranolol—Constipation—Docetaxel—head and neck cancer	0.000198	0.00344	CcSEcCtD
Propranolol—Pain—Docetaxel—head and neck cancer	0.000198	0.00344	CcSEcCtD
Propranolol—Nausea—Fluorouracil—head and neck cancer	0.00019	0.00331	CcSEcCtD
Propranolol—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000189	0.00329	CcSEcCtD
Propranolol—Abdominal pain—Docetaxel—head and neck cancer	0.000183	0.00318	CcSEcCtD
Propranolol—Body temperature increased—Docetaxel—head and neck cancer	0.000183	0.00318	CcSEcCtD
Propranolol—Hypersensitivity—Docetaxel—head and neck cancer	0.00017	0.00296	CcSEcCtD
Propranolol—Asthenia—Docetaxel—head and neck cancer	0.000166	0.00289	CcSEcCtD
Propranolol—Diarrhoea—Docetaxel—head and neck cancer	0.000158	0.00275	CcSEcCtD
Propranolol—Dizziness—Docetaxel—head and neck cancer	0.000153	0.00266	CcSEcCtD
Propranolol—Vomiting—Docetaxel—head and neck cancer	0.000147	0.00256	CcSEcCtD
Propranolol—Rash—Docetaxel—head and neck cancer	0.000146	0.00254	CcSEcCtD
Propranolol—Dermatitis—Docetaxel—head and neck cancer	0.000145	0.00253	CcSEcCtD
Propranolol—Nausea—Docetaxel—head and neck cancer	0.000137	0.00239	CcSEcCtD
Propranolol—CYP3A7—Metabolism—DPYD—head and neck cancer	1.26e-05	0.000974	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—DPYD—head and neck cancer	1.25e-05	0.000972	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	1.23e-05	0.000955	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—GRP—head and neck cancer	1.22e-05	0.000944	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—YAP1—head and neck cancer	1.19e-05	0.000924	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—GRP—head and neck cancer	1.19e-05	0.000923	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—YAP1—head and neck cancer	1.19e-05	0.000923	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—STAT6—head and neck cancer	1.18e-05	0.000916	CbGpPWpGaD
Propranolol—SLC22A2—Transmission across Chemical Synapses—HRAS—head and neck cancer	1.17e-05	0.000911	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	1.17e-05	0.000907	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.17e-05	0.000903	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—GRP—head and neck cancer	1.16e-05	0.000903	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—UROD—head and neck cancer	1.16e-05	0.000899	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—STAT6—head and neck cancer	1.16e-05	0.000896	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—STAT6—head and neck cancer	1.13e-05	0.000876	CbGpPWpGaD
Propranolol—SLC22A2—Neuronal System—MAPK1—head and neck cancer	1.12e-05	0.000869	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	1.06e-05	0.000819	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—YAP1—head and neck cancer	1.05e-05	0.000811	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.04e-05	0.000805	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—NAT2—head and neck cancer	1.04e-05	0.000803	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—YAP1—head and neck cancer	1.02e-05	0.000793	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	1.02e-05	0.000791	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—IL2—head and neck cancer	1.02e-05	0.00079	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—YAP1—head and neck cancer	1e-05	0.000775	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—NAT2—head and neck cancer	9.78e-06	0.000758	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—IL2—head and neck cancer	9.25e-06	0.000717	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	9.22e-06	0.000714	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—DPYD—head and neck cancer	9.08e-06	0.000704	CbGpPWpGaD
Propranolol—SLC22A2—Neuronal System—HRAS—head and neck cancer	9e-06	0.000698	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	8.72e-06	0.000676	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—YAP1—head and neck cancer	8.62e-06	0.000668	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—DPYD—head and neck cancer	8.58e-06	0.000665	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.5e-06	0.000659	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.42e-06	0.000652	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	8.29e-06	0.000643	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	8.29e-06	0.000643	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—YAP1—head and neck cancer	8.14e-06	0.000631	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—NAT2—head and neck cancer	8.01e-06	0.000621	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—NOTCH1—head and neck cancer	7.94e-06	0.000616	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—NAT2—head and neck cancer	7.81e-06	0.000606	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—IL2—head and neck cancer	7.59e-06	0.000589	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—MAPK3—head and neck cancer	7.44e-06	0.000576	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—NAT2—head and neck cancer	7.36e-06	0.000571	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	7.2e-06	0.000558	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—TYMS—head and neck cancer	7.16e-06	0.000555	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—TYMS—head and neck cancer	7.15e-06	0.000554	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—MAPK1—head and neck cancer	7.08e-06	0.000549	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—GSTM1—head and neck cancer	7.08e-06	0.000548	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—EGFR—head and neck cancer	7.08e-06	0.000548	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—GSTM1—head and neck cancer	7.06e-06	0.000548	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—DPYD—head and neck cancer	7.02e-06	0.000544	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	6.96e-06	0.00054	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—IL2—head and neck cancer	6.89e-06	0.000534	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—DPYD—head and neck cancer	6.85e-06	0.000531	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—GPX1—head and neck cancer	6.78e-06	0.000525	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—GPX1—head and neck cancer	6.76e-06	0.000524	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—PIK3CA—head and neck cancer	6.76e-06	0.000524	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—CYP1A1—head and neck cancer	6.71e-06	0.00052	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—CYP1A1—head and neck cancer	6.7e-06	0.000519	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—YAP1—head and neck cancer	6.66e-06	0.000516	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.62e-06	0.000514	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.56e-06	0.000508	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—YAP1—head and neck cancer	6.5e-06	0.000504	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—DPYD—head and neck cancer	6.46e-06	0.0005	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—NAT2—head and neck cancer	6.24e-06	0.000484	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—PIK3CA—head and neck cancer	6.14e-06	0.000476	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—YAP1—head and neck cancer	6.13e-06	0.000475	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	6.12e-06	0.000474	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—IL2—head and neck cancer	6.05e-06	0.000469	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—NOTCH1—head and neck cancer	5.92e-06	0.000459	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—IL2—head and neck cancer	5.91e-06	0.000458	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	5.88e-06	0.000456	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—IL2—head and neck cancer	5.78e-06	0.000448	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—HRAS—head and neck cancer	5.68e-06	0.00044	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—MAPK3—head and neck cancer	5.54e-06	0.00043	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—AKT1—head and neck cancer	5.52e-06	0.000428	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—IL2—head and neck cancer	5.49e-06	0.000426	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—DPYD—head and neck cancer	5.47e-06	0.000424	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—IL2—head and neck cancer	5.46e-06	0.000424	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—IL2—head and neck cancer	5.37e-06	0.000416	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.33e-06	0.000413	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—CCND1—head and neck cancer	5.33e-06	0.000413	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—MAPK1—head and neck cancer	5.27e-06	0.000409	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—EGFR—head and neck cancer	5.27e-06	0.000409	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—IL2—head and neck cancer	5.25e-06	0.000407	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—YAP1—head and neck cancer	5.19e-06	0.000402	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—TYMS—head and neck cancer	5.17e-06	0.000401	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—PTEN—head and neck cancer	5.14e-06	0.000399	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—GSTM1—head and neck cancer	5.11e-06	0.000396	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—PIK3CA—head and neck cancer	5.04e-06	0.000391	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—AKT1—head and neck cancer	5.02e-06	0.000389	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.01e-06	0.000388	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—GPX1—head and neck cancer	4.9e-06	0.00038	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—TYMS—head and neck cancer	4.89e-06	0.000379	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—CYP1A1—head and neck cancer	4.85e-06	0.000376	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—GSTM1—head and neck cancer	4.83e-06	0.000375	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NAT2—head and neck cancer	4.81e-06	0.000373	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—NOTCH1—head and neck cancer	4.71e-06	0.000365	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—VEGFA—head and neck cancer	4.64e-06	0.00036	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—GPX1—head and neck cancer	4.63e-06	0.000359	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—NOTCH1—head and neck cancer	4.61e-06	0.000357	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—STAT3—head and neck cancer	4.6e-06	0.000356	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—PIK3CA—head and neck cancer	4.58e-06	0.000355	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—NOTCH1—head and neck cancer	4.51e-06	0.000349	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—MAPK3—head and neck cancer	4.41e-06	0.000342	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—MAPK3—head and neck cancer	4.39e-06	0.000341	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.37e-06	0.000338	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—MAPK3—head and neck cancer	4.32e-06	0.000335	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—HRAS—head and neck cancer	4.23e-06	0.000328	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—MAPK3—head and neck cancer	4.22e-06	0.000327	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—DPYD—head and neck cancer	4.22e-06	0.000327	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—MAPK1—head and neck cancer	4.2e-06	0.000326	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—EGFR—head and neck cancer	4.2e-06	0.000326	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—MAPK1—head and neck cancer	4.18e-06	0.000324	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—EGFR—head and neck cancer	4.18e-06	0.000324	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—AKT1—head and neck cancer	4.12e-06	0.000319	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—MAPK1—head and neck cancer	4.11e-06	0.000318	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—EGFR—head and neck cancer	4.11e-06	0.000318	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IL2—head and neck cancer	4.07e-06	0.000316	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—MAPK1—head and neck cancer	4.02e-06	0.000311	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—EGFR—head and neck cancer	4.02e-06	0.000311	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—PIK3CA—head and neck cancer	4.01e-06	0.000311	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—YAP1—head and neck cancer	4.01e-06	0.000311	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—TYMS—head and neck cancer	4e-06	0.00031	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PTGS2—head and neck cancer	3.99e-06	0.000309	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PTGS2—head and neck cancer	3.98e-06	0.000309	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CCND1—head and neck cancer	3.97e-06	0.000308	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GSTM1—head and neck cancer	3.95e-06	0.000306	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—PIK3CA—head and neck cancer	3.93e-06	0.000304	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—TYMS—head and neck cancer	3.9e-06	0.000303	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.9e-06	0.000302	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GSTM1—head and neck cancer	3.86e-06	0.000299	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—PIK3CA—head and neck cancer	3.84e-06	0.000298	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—PTEN—head and neck cancer	3.83e-06	0.000297	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GPX1—head and neck cancer	3.79e-06	0.000294	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.76e-06	0.000292	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CYP1A1—head and neck cancer	3.75e-06	0.000291	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—AKT1—head and neck cancer	3.74e-06	0.00029	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GPX1—head and neck cancer	3.7e-06	0.000286	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—TYMS—head and neck cancer	3.68e-06	0.000285	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CYP1A1—head and neck cancer	3.66e-06	0.000284	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—PIK3CA—head and neck cancer	3.64e-06	0.000283	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GSTM1—head and neck cancer	3.64e-06	0.000282	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—PIK3CA—head and neck cancer	3.63e-06	0.000281	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—PIK3CA—head and neck cancer	3.57e-06	0.000276	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—TP53—head and neck cancer	3.51e-06	0.000272	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—PIK3CA—head and neck cancer	3.49e-06	0.00027	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GPX1—head and neck cancer	3.48e-06	0.00027	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PTEN—head and neck cancer	3.48e-06	0.00027	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PTEN—head and neck cancer	3.47e-06	0.000269	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—VEGFA—head and neck cancer	3.46e-06	0.000268	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CYP1A1—head and neck cancer	3.45e-06	0.000267	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—STAT3—head and neck cancer	3.43e-06	0.000266	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.4e-06	0.000264	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—HRAS—head and neck cancer	3.37e-06	0.000261	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—HRAS—head and neck cancer	3.36e-06	0.00026	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—HRAS—head and neck cancer	3.3e-06	0.000256	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—AKT1—head and neck cancer	3.28e-06	0.000254	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MAPK3—head and neck cancer	3.27e-06	0.000254	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL2—head and neck cancer	3.24e-06	0.000251	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—HRAS—head and neck cancer	3.23e-06	0.00025	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—AKT1—head and neck cancer	3.21e-06	0.000249	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL2—head and neck cancer	3.17e-06	0.000246	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CCND1—head and neck cancer	3.16e-06	0.000245	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—AKT1—head and neck cancer	3.14e-06	0.000243	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—TYMS—head and neck cancer	3.12e-06	0.000242	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MAPK1—head and neck cancer	3.12e-06	0.000241	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—EGFR—head and neck cancer	3.11e-06	0.000241	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL2—head and neck cancer	3.1e-06	0.00024	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CCND1—head and neck cancer	3.09e-06	0.00024	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GSTM1—head and neck cancer	3.08e-06	0.000239	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.08e-06	0.000239	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PTEN—head and neck cancer	3.05e-06	0.000237	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CCND1—head and neck cancer	3.02e-06	0.000234	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PTEN—head and neck cancer	2.99e-06	0.000231	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—AKT1—head and neck cancer	2.98e-06	0.000231	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—AKT1—head and neck cancer	2.96e-06	0.00023	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GPX1—head and neck cancer	2.95e-06	0.000229	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CYP1A1—head and neck cancer	2.92e-06	0.000226	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PTEN—head and neck cancer	2.92e-06	0.000226	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—AKT1—head and neck cancer	2.91e-06	0.000226	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PTGS2—head and neck cancer	2.88e-06	0.000223	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—AKT1—head and neck cancer	2.85e-06	0.000221	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—VEGFA—head and neck cancer	2.76e-06	0.000214	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—STAT3—head and neck cancer	2.73e-06	0.000212	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PTGS2—head and neck cancer	2.72e-06	0.000211	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—PIK3CA—head and neck cancer	2.7e-06	0.00021	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—VEGFA—head and neck cancer	2.7e-06	0.000209	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—STAT3—head and neck cancer	2.67e-06	0.000207	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—VEGFA—head and neck cancer	2.64e-06	0.000204	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TP53—head and neck cancer	2.62e-06	0.000203	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—STAT3—head and neck cancer	2.61e-06	0.000202	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MAPK3—head and neck cancer	2.61e-06	0.000202	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MAPK3—head and neck cancer	2.55e-06	0.000198	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PTEN—head and neck cancer	2.51e-06	0.000195	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—HRAS—head and neck cancer	2.5e-06	0.000194	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MAPK3—head and neck cancer	2.49e-06	0.000193	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MAPK1—head and neck cancer	2.48e-06	0.000192	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—EGFR—head and neck cancer	2.48e-06	0.000192	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PIK3CA—head and neck cancer	2.45e-06	0.00019	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PIK3CA—head and neck cancer	2.45e-06	0.00019	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MAPK1—head and neck cancer	2.43e-06	0.000188	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—EGFR—head and neck cancer	2.43e-06	0.000188	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—TYMS—head and neck cancer	2.41e-06	0.000186	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.4e-06	0.000186	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.38e-06	0.000184	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PTEN—head and neck cancer	2.38e-06	0.000184	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MAPK1—head and neck cancer	2.37e-06	0.000184	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—EGFR—head and neck cancer	2.37e-06	0.000184	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GPX1—head and neck cancer	2.28e-06	0.000176	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.25e-06	0.000175	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PTGS2—head and neck cancer	2.23e-06	0.000173	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—AKT1—head and neck cancer	2.21e-06	0.000171	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PTGS2—head and neck cancer	2.18e-06	0.000169	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PIK3CA—head and neck cancer	2.15e-06	0.000167	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PIK3CA—head and neck cancer	2.11e-06	0.000163	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TP53—head and neck cancer	2.08e-06	0.000161	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PIK3CA—head and neck cancer	2.06e-06	0.00016	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PTGS2—head and neck cancer	2.05e-06	0.000159	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TP53—head and neck cancer	2.04e-06	0.000158	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—AKT1—head and neck cancer	2e-06	0.000155	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—AKT1—head and neck cancer	2e-06	0.000155	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TP53—head and neck cancer	1.99e-06	0.000154	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—HRAS—head and neck cancer	1.99e-06	0.000154	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—HRAS—head and neck cancer	1.95e-06	0.000151	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PTEN—head and neck cancer	1.94e-06	0.000151	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—HRAS—head and neck cancer	1.91e-06	0.000148	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PTEN—head and neck cancer	1.9e-06	0.000147	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PTEN—head and neck cancer	1.79e-06	0.000139	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3CA—head and neck cancer	1.77e-06	0.000138	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—AKT1—head and neck cancer	1.76e-06	0.000136	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.74e-06	0.000135	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—AKT1—head and neck cancer	1.72e-06	0.000133	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—AKT1—head and neck cancer	1.68e-06	0.00013	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CA—head and neck cancer	1.68e-06	0.00013	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PTEN—head and neck cancer	1.51e-06	0.000117	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—AKT1—head and neck cancer	1.45e-06	0.000112	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CA—head and neck cancer	1.37e-06	0.000106	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—AKT1—head and neck cancer	1.37e-06	0.000106	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.34e-06	0.000104	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.34e-06	0.000104	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CA—head and neck cancer	1.26e-06	9.78e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PTEN—head and neck cancer	1.17e-06	9.06e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—AKT1—head and neck cancer	1.12e-06	8.68e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—AKT1—head and neck cancer	1.09e-06	8.48e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.07e-06	8.28e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—AKT1—head and neck cancer	1.03e-06	7.99e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—AKT1—head and neck cancer	8.73e-07	6.77e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CA—head and neck cancer	8.25e-07	6.39e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—AKT1—head and neck cancer	6.74e-07	5.22e-05	CbGpPWpGaD
